Sondashi Formula providing an alternative and cheap source of anti HIV therapy for the region and the world - African Union’s NEPAD programme.

By John Chola – 26 /10 /12

The African Union’s New Partnership for Africa's Development (NEPAD), a programme adopted in Lusaka, Zambia in 2001, says preliminary results had showed in 2007 that the early scientific evidence have substantiated the traditional use of the Sondashi Formula (SF 2000). This was as observed against the HIV Subtype C strain when compared to subtype with a corresponding significant higher viral selectivity index for peripheral blood mononuclear cells. NEPAD through its Southern African Network for Biosciences (NEPAD SANBio NETWORK) described the results of the SF-2000 interesting findings that are of great importance to it and the region.

"A significantly increased anti-viral activity for the Sondashi Formula (SF-2000) was observed against the HIV Sub type B with a corresponding significant higher viral selectivity index for peripheral blood mononuclear cells. Of significance, the Subtype C strain is the more relevant to Africa," says Professor Luke Mumba, Director of the NEPAD SANBio NETWORK. Prof. Mumba said the SF-2000 is also providing an alternative and cheap source of anti HIV therapy for the region and the world who cannot afford to buy ART drugs at present. End…##